1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2019The Kiplinger Washington Editors
The fallout in biotech stocks has created risky, but enticing, opportunities.
After six disappointing years, small-company specialist Warren Isabelle appears to have righted his ship.
Investors may cherish dividend stocks, which provide a regular stream of income that allows you to realize regular profits along the way without having to sell your stock. But they get twitchy around...
More Investing News »